Managing cytopenias: The path to transfusion independence for patients with myelofibrosis

Innovations and advances in CML: Focus on navigating early-line options and maintaining quality of life

Breakthroughs in treating NSCLC: Targeting KRAS

HER2 in focus: Advancing treatment for biliary tract and gastroesophageal cancers

Delivering state-of-the-art care for GEP-NETs: Evidence-based strategies for PRRT

Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC

Eyeing better outcomes in diabetic macular oedema: Clinical insights on the evolving role of corticosteroids

Diagnosis and treatment of patients with Lennox–Gastaut syndrome

Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies

Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC

Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages

FCS unmasked: Closing gaps in diagnosis, treatment and patient support

Achieving effective lifespan care in sickle cell disease: From recognizing the burden to novel therapeutics

Bridging diagnostic and therapeutic gaps in Fabry disease management

Applying patient and disease characteristics to guide R/M NPC treatment

Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?

Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes

Stargardt disease: Improving awareness, diagnosis and patient support

Mastering DKA management: From pathophysiology to prevention and ketone monitoring strategies

A case-based discussion on PAH: Optimizing early detection, risk stratification and treatment decision-making